Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

North Andover, Massachusetts 01845


Purpose:

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis


Study summary:

Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular anti-allergic therapy in the prevention of ocular allergic symptoms.


Criteria:

Inclusion Criteria: - At least 18 years of age & either sex, any race - Willing and able to follow all instructions and attend all study visits - Positive history of ocular allergies - Reproducible positive ocular allergic reaction induced by conjunctival allergen challenge Exclusion Criteria: - Have planned surgery during trial period - Female currently pregnant, planning a pregnancy, or lactating - Use of disallowed medications


NCT ID:

NCT00655109


Primary Contact:

Principal Investigator
Jack V Greiner, OD, DO, PhD
ORA, Inc.


Backup Contact:

N/A


Location Contact:

North Andover, Massachusetts 01845
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.